Export
export
Export
PDF
Excel (XLSX)
Word (DOCX)
You can select particular sections to be included in the output file.
Select all
Select classic EML layout
Indication
ICD-11
ATC codes
List type
Formulations
Therapeutic alternatives
Footnote
INN
Medicine type
Antibiotic groups
Sex
Age
Age restriction
Weight restriction
Patent information
Expert Committee decision justification
Cancel
Download
Model List of Essential Medicines
clear
Found 12 recommendations for 8 medicines and 4 therapeutic equivalents
Removed medicines and rejected applications are not shown.
Show them
.
8.1. Immunomodulators for non-malignant disease
Adalimumab
General information
Section
Immunomodulators for non-malignant disease
Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL
Indications
Axial spondyloarthritis
Rheumatoid arthritis
Crohn disease site
Azathioprine
General information
Section
Immunomodulators for non-malignant disease
Parenteral > General injections > IV: 100 mg in vial powder for injection (as sodium salt); 50 mg in vial powder for injection (as sodium salt)
Oral > Liquid: 10 mg per mL
Oral > Solid > tablet: 50 mg (scored); 25 mg
Indications
Failure or rejection of transplanted organs or tissues
Certolizumab pegol
General information
Section
Immunomodulators for non-malignant disease
Indications
Therapeutic equivalent to
adalimumab
for
Axial spondyloarthritis
Therapeutic equivalent to
adalimumab
for
Rheumatoid arthritis
Therapeutic equivalent to
adalimumab
for
Crohn disease site
Ciclosporin
General information
Section
Immunomodulators for non-malignant disease
Parenteral > General injections > IV: 50 mg per mL in 1 mL ampoule concentrate for injection
Oral > Liquid: 100 mg per mL
Oral > Solid > capsule: 25 mg
Indications
Failure or rejection of transplanted organs or tissues
Etanercept
General information
Section
Immunomodulators for non-malignant disease
Indications
Therapeutic equivalent to
adalimumab
for
Axial spondyloarthritis
Therapeutic equivalent to
adalimumab
for
Rheumatoid arthritis
Therapeutic equivalent to
adalimumab
for
Crohn disease site
Golimumab
General information
Section
Immunomodulators for non-malignant disease
Indications
Therapeutic equivalent to
adalimumab
for
Axial spondyloarthritis
Therapeutic equivalent to
adalimumab
for
Rheumatoid arthritis
Therapeutic equivalent to
adalimumab
for
Crohn disease site
Infliximab
General information
Section
Immunomodulators for non-malignant disease
Indications
Therapeutic equivalent to
adalimumab
for
Axial spondyloarthritis
Therapeutic equivalent to
adalimumab
for
Rheumatoid arthritis
Therapeutic equivalent to
adalimumab
for
Crohn disease site
Tacrolimus
General information
Section
Immunomodulators for non-malignant disease
Parenteral > General injections > IV: 5 mg per mL in 1 mL vial
Oral > Liquid: 0.2 mg granules for oral suspension; 1 mg granules for oral suspension
Oral > Solid: 0.5 mg (immediate-release); 0.75 mg (immediate-release); 1 mg (immediate-release); 2 mg (immediate-release); 5 mg (immediate-release)
Indications
Failure or rejection of transplanted organs or tissues